The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mesenchymal Stem Cells-Global Market Insights and Sales Trends 2025
Synopsis
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
The global Mesenchymal Stem Cells market size is expected to reach US$ 282.9 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Mesenchymal Stem Cells in various end use industries. The expanding demands from the Research Institute, Hospital and Others,, are propelling Mesenchymal Stem Cells market. Human MSC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mouse MSC segment is estimated at % CAGR for the next seven-year period.
The top 3 manufacturters of Mesenchymal Stem Cells include Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mesenchymal Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mesenchymal Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mesenchymal Stem Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mesenchymal Stem Cells covered in this report include Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen and Cell Applications, etc.
The global Mesenchymal Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience
Global Mesenchymal Stem Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mesenchymal Stem Cells market, Segment by Type:
Human MSC
Mouse MSC
Rat MSC
Others
Global Mesenchymal Stem Cells market, by Application
Research Institute
Hospital
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mesenchymal Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
The global Mesenchymal Stem Cells market size is expected to reach US$ 282.9 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Mesenchymal Stem Cells in various end use industries. The expanding demands from the Research Institute, Hospital and Others,, are propelling Mesenchymal Stem Cells market. Human MSC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mouse MSC segment is estimated at % CAGR for the next seven-year period.
The top 3 manufacturters of Mesenchymal Stem Cells include Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mesenchymal Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mesenchymal Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mesenchymal Stem Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mesenchymal Stem Cells covered in this report include Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen and Cell Applications, etc.
The global Mesenchymal Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience
Global Mesenchymal Stem Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mesenchymal Stem Cells market, Segment by Type:
Human MSC
Mouse MSC
Rat MSC
Others
Global Mesenchymal Stem Cells market, by Application
Research Institute
Hospital
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mesenchymal Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Mesenchymal Stem Cells
1.1 Mesenchymal Stem Cells Market Overview
1.1.1 Mesenchymal Stem Cells Product Scope
1.1.2 Mesenchymal Stem Cells Market Status and Outlook
1.2 Global Mesenchymal Stem Cells Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Mesenchymal Stem Cells Market Size by Region (2018-2029)
1.4 Global Mesenchymal Stem Cells Historic Market Size by Region (2018-2023)
1.5 Global Mesenchymal Stem Cells Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Mesenchymal Stem Cells Market Size (2018-2029)
1.6.1 North America Mesenchymal Stem Cells Market Size (2018-2029)
1.6.2 Europe Mesenchymal Stem Cells Market Size (2018-2029)
1.6.3 Asia-Pacific Mesenchymal Stem Cells Market Size (2018-2029)
1.6.4 Latin America Mesenchymal Stem Cells Market Size (2018-2029)
1.6.5 Middle East & Africa Mesenchymal Stem Cells Market Size (2018-2029)
2 Mesenchymal Stem Cells Market by Type
2.1 Introduction
2.1.1 Human MSC
2.1.2 Mouse MSC
2.1.3 Rat MSC
2.1.4 Others
2.2 Global Mesenchymal Stem Cells Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Mesenchymal Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Mesenchymal Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Mesenchymal Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Mesenchymal Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Mesenchymal Stem Cells Revenue Breakdown by Type (2018-2029)
3 Mesenchymal Stem Cells Market Overview by Application
3.1 Introduction
3.1.1 Research Institute
3.1.2 Hospital
3.1.3 Others
3.2 Global Mesenchymal Stem Cells Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Mesenchymal Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Mesenchymal Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Mesenchymal Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Mesenchymal Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Mesenchymal Stem Cells Revenue Breakdown by Application (2018-2029)
4 Mesenchymal Stem Cells Competition Analysis by Players
4.1 Global Mesenchymal Stem Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mesenchymal Stem Cells as of 2022)
4.3 Date of Key Players Enter into Mesenchymal Stem Cells Market
4.4 Global Top Players Mesenchymal Stem Cells Headquarters and Area Served
4.5 Key Players Mesenchymal Stem Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Mesenchymal Stem Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business
5.1.3 Lonza Mesenchymal Stem Cells Products, Services and Solutions
5.1.4 Lonza Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Lonza Recent Developments
5.2 Thermo Fisher
5.2.1 Thermo Fisher Profile
5.2.2 Thermo Fisher Main Business
5.2.3 Thermo Fisher Mesenchymal Stem Cells Products, Services and Solutions
5.2.4 Thermo Fisher Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Recent Developments
5.3 Bio-Techne
5.3.1 Bio-Techne Profile
5.3.2 Bio-Techne Main Business
5.3.3 Bio-Techne Mesenchymal Stem Cells Products, Services and Solutions
5.3.4 Bio-Techne Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.3.5 ATCC Recent Developments
5.4 ATCC
5.4.1 ATCC Profile
5.4.2 ATCC Main Business
5.4.3 ATCC Mesenchymal Stem Cells Products, Services and Solutions
5.4.4 ATCC Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.4.5 ATCC Recent Developments
5.5 MilliporeSigma
5.5.1 MilliporeSigma Profile
5.5.2 MilliporeSigma Main Business
5.5.3 MilliporeSigma Mesenchymal Stem Cells Products, Services and Solutions
5.5.4 MilliporeSigma Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.5.5 MilliporeSigma Recent Developments
5.6 PromoCell GmbH
5.6.1 PromoCell GmbH Profile
5.6.2 PromoCell GmbH Main Business
5.6.3 PromoCell GmbH Mesenchymal Stem Cells Products, Services and Solutions
5.6.4 PromoCell GmbH Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.6.5 PromoCell GmbH Recent Developments
5.7 Genlantis
5.7.1 Genlantis Profile
5.7.2 Genlantis Main Business
5.7.3 Genlantis Mesenchymal Stem Cells Products, Services and Solutions
5.7.4 Genlantis Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.7.5 Genlantis Recent Developments
5.8 Celprogen
5.8.1 Celprogen Profile
5.8.2 Celprogen Main Business
5.8.3 Celprogen Mesenchymal Stem Cells Products, Services and Solutions
5.8.4 Celprogen Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Celprogen Recent Developments
5.9 Cell Applications
5.9.1 Cell Applications Profile
5.9.2 Cell Applications Main Business
5.9.3 Cell Applications Mesenchymal Stem Cells Products, Services and Solutions
5.9.4 Cell Applications Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.9.5 Cell Applications Recent Developments
5.10 Cyagen Biosciences
5.10.1 Cyagen Biosciences Profile
5.10.2 Cyagen Biosciences Main Business
5.10.3 Cyagen Biosciences Mesenchymal Stem Cells Products, Services and Solutions
5.10.4 Cyagen Biosciences Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.10.5 Cyagen Biosciences Recent Developments
5.11 Axol Bioscience
5.11.1 Axol Bioscience Profile
5.11.2 Axol Bioscience Main Business
5.11.3 Axol Bioscience Mesenchymal Stem Cells Products, Services and Solutions
5.11.4 Axol Bioscience Mesenchymal Stem Cells Revenue (US$ Million) & (2018-2023)
5.11.5 Axol Bioscience Recent Developments
6 North America
6.1 North America Mesenchymal Stem Cells Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Mesenchymal Stem Cells Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mesenchymal Stem Cells Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mesenchymal Stem Cells Market Dynamics
11.1 Mesenchymal Stem Cells Industry Trends
11.2 Mesenchymal Stem Cells Market Drivers
11.3 Mesenchymal Stem Cells Market Challenges
11.4 Mesenchymal Stem Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
